home.aspx
 
. https://pharmaceutical.report/Resources/Whitepapers/7f6d04e8-70c0-4628-99f3-e62c9f19c0b6_Whitepaper_Econometric Analysis of Biopharmaceutical Transfer Pricing.pdf
whitepaper
SHARESHARESHARE
ECONOMETRIC ANALYSIS OF BIOPHARMACEUTICAL TRANSFER PRICING
Interestingly, the above quote by Benjamin Franklin epitomizes in many respects the significant daily challenges faced by biopharmaceutical companies – to lengthen and improve the quality of life, while always facing the mortality of patients against increasingly challenging diseases, and at the same time engaged in pursuing this noble endeavor in a prudent economic fashion. This white paper goes outside the traditional boundaries of biopharmaceutical commercial analytics to explore a topic noted in the second part of Benjamin Franklin’s quote – taxes. In particular, this white paper will explore the application of econometric analysis of biopharmaceutical transfer pricing, a direct result of differentials in cross-country corporate income tax rates. Given disparities in the US corporate income tax rate relative to other developed countries with major biopharmaceutical operations, this is a white paper that deserves your attention, and will guarantee not to “tax” you (pun intended). DOWNLOAD